David S. Baldwin

25.4k total citations · 1 hit paper
447 papers, 16.2k citations indexed

About

David S. Baldwin is a scholar working on Experimental and Cognitive Psychology, Clinical Psychology and Psychiatry and Mental health. According to data from OpenAlex, David S. Baldwin has authored 447 papers receiving a total of 16.2k indexed citations (citations by other indexed papers that have themselves been cited), including 160 papers in Experimental and Cognitive Psychology, 138 papers in Clinical Psychology and 114 papers in Psychiatry and Mental health. Recurrent topics in David S. Baldwin's work include Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (123 papers), Treatment of Major Depression (101 papers) and Child and Adolescent Psychosocial and Emotional Development (61 papers). David S. Baldwin is often cited by papers focused on Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (123 papers), Treatment of Major Depression (101 papers) and Child and Adolescent Psychosocial and Emotional Development (61 papers). David S. Baldwin collaborates with scholars based in United Kingdom, United States and South Africa. David S. Baldwin's co-authors include David Bartram, Andrew Mayers, Gloria R. Gallo, Dan J. Stein, Robert T. McCluskey, Matthew Garner, Borwin Bandelow, Jerome Lowenstein, Joel Neugarten and Peter Tyrer and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Circulation.

In The Last Decade

David S. Baldwin

424 papers receiving 14.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: A revision of the 2005 guidelines from the British Association for Psychopharmacology

2014 429 citations David S. Baldwin, David Nutt et al. Journal of Psychopharmacology profile →

Peers

Countries citing papers authored by David S. Baldwin

Since Specialization

Citations

This map shows the geographic impact of David S. Baldwin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David S. Baldwin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David S. Baldwin more than expected).

Fields of papers citing papers by David S. Baldwin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David S. Baldwin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David S. Baldwin. The network helps show where David S. Baldwin may publish in the future.

Co-authorship network of co-authors of David S. Baldwin

This figure shows the co-authorship network connecting the top 25 collaborators of David S. Baldwin. A scholar is included among the top collaborators of David S. Baldwin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David S. Baldwin. David S. Baldwin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effects of transcranial direct current stimulation (tDCS) at different cortical targets on cognition in obsessive-compulsive disorder (OCD): an exploratory analysis 2025 ·International Clinical Psychopharmacology ·Luca Pellegrini, Eduardo Cinosi, David Wellsted, Megan Smith, Amanda Busby, Natalie Hall, Umberto Albert, (unknown), Matthew Garner, Samuel R. Chamberlain, Trevor W. Robbins, David S. Baldwin, Naomi Fineberg	0
2	Relationship between anhedonia, separation anxiety, attachment style and suicidality in a large cohort of individuals with mood and anxiety disorders 2025 ·Journal of Affective Disorders ·Stefano Pini, Barbara Milrod, Benedetta Nardi, Gabriele Massimetti, (unknown), David S. Baldwin, Katharina Domschke, Miriam A. Schiele, Lilliana Dell’Osso, (unknown)	0
3	Mental health homicide inquiries in England 2010–2023: review of methodology and findings 2025 ·The British Journal of Psychiatry ·(unknown), Julia Sinclair, (unknown), David S. Baldwin	0
4	Transcranial Magnetic Stimulation and Transcranial Direct Current Stimulation Across Mental Disorders 2024 ·JAMA Network Open ·Michel Sabé, Joshua Hyde, (unknown), (unknown), Alessio Crippa, André R. Brunoni, André Alemán, Stefan Kaiser, David S. Baldwin, Matthew Garner, Othman Sentissi, Jess G. Fiedorowicz, Valerie Brandt, Samuele Cortese, Marco Solmi	22
5	Apathy associated with antidepressant drugs: a systematic review 2023 ·Acta Neuropsychiatrica ·Vasilios G. Masdrakis, Manolis Markianos, David S. Baldwin	16
6	Could improved recognition and treatment of anxiety disorders lead to a reduction in suicide? 2023 ·Human Psychopharmacology Clinical and Experimental ·Vasilios G. Masdrakis, (unknown), David S. Baldwin	0
7	The relationship of separation anxiety with the age of onset of panic disorder 2023 ·Early Intervention in Psychiatry ·Stefano Pini, Barbara Milrod, David S. Baldwin, Miriam A. Schiele, Gabriele Massimetti, Barbara Costa, Claudia Martini, Borwin Bandelow, Katharina Domschke, Marianna Abelli	2
8	Selective serotonin reuptake inhibitors, post‐treatment sexual dysfunction and persistent genital arousal disorder: A systematic review 2023 ·Pharmacoepidemiology and Drug Safety ·Livio Tarchi, (unknown), (unknown), (unknown), Emanuele Cassioli, Eleonora Rossi, Mario Maggi, David S. Baldwin, Valdo Ricca, Giovanni Castellini	8
9	The roles of a psychiatrist in the COVID-19 pandemic 2021 ·ePrints Soton (University of Southampton) ·David S. Baldwin, (unknown), (unknown)	3
10	Brain Functional Connectivity Correlates of Response in the 7.5% CO2 Inhalational Model of Generalized Anxiety Disorder: A Pilot Study 2020 ·The International Journal of Neuropsychopharmacology ·Nathan T. M. Huneke, (unknown), Angela Darekar, David S. Baldwin, Matthew Garner	4
11	Hair cortisol concentration in anxiety disorders: exploration of relationships with symptom severity and inflammatory markers 2020 ·Acta Neuropsychiatrica ·(unknown), Laurie C.K. Lau, (unknown), David S. Baldwin	9
12	Benzodiazepines: Risks and benefits. A reconsideration 2013 ·Journal of Psychopharmacology ·David S. Baldwin, Katherine J. Aitchison, Alan N. Bateson, Valerie H. Curran, Simon Davies, Brian E. Leonard, David Nutt, David Stephens, Sue Wilson	159
13	Reduced Treatment-Emergent Sexual Dysfunction as a Potential Target in the Development of New Antidepressants 2013 ·Depression Research and Treatment ·David S. Baldwin, Carlotta Palazzo, Vasilios G. Masdrakis	21
14	British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders 2010 ·Journal of Psychopharmacology ·SJ Wilson, DJ NUTT, Chris Alford, S. Argyropoulos, David S. Baldwin, (unknown), TC Britton, Catherine Crowe, Derk‐Jan Dijk, Colin A. Espie, Paul Gringras, G. Hajak, C. Idzikowski, (unknown), (unknown), Hugh Selsick, Ann L. Sharpley, (unknown)	467
15	Agomelatine in the treatment of mood and anxiety disorders 2010 ·British Journal of Hospital Medicine ·David S. Baldwin, (unknown)	1
16	A Pooled Analysis of Gender and Trauma-Type Effects on Responsiveness to Treatment of PTSD With Venlafaxine Extended Release or Placebo 2008 ·The Journal of Clinical Psychiatry ·Barbara O. Rothbaum, Jonathan Davidson, Dan J. Stein, Raymond A. Pederson, Jeff Musgnung, (unknown), Saeeduddin Ahmed, David S. Baldwin	19
17	Antidepressant-induced sexual dysfunction in three European countries: prevalence and impact in a cross-sectional survey replication 2007 ·ePrints Soton (University of Southampton) ·Valerie Williams, Heather M. Edin, S. Hogue, Sheri Fehnel, David S. Baldwin	1
18	Qualitative changes in symptomatology before and after treatment to remission in generalised anxiety disorder and major depression 2006 ·ePrints Soton (University of Southampton) ·Y. Lecrubier, E. Weiller, Henning Andersen, David S. Baldwin	2
19	Discontinuation symptoms in affective disorders 2005 ·ePrints Soton (University of Southampton) ·David S. Baldwin, S.A. Montgomery, R. Nil, M. Lader	1
20	The tolerability of venlafaxine 1998 ·ePrints Soton (University of Southampton) ·Julia Sinclair, Jon Birtwistle, David S. Baldwin	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact